title: Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)?
authors.affiliation: Department of Anesthesiology, University Hospital Bergmannsheil, Bochum, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Zenz
authors.forename: B
authors.initials: B
authors.lastname: Donner
authors.forename: M
authors.initials: M
authors.lastname: Strumpf
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D003110:Colonic Neoplasms / Q000503:physiopathology*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000503:physiopathology*; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care; D012008:Recurrence; D013375:Substance Withdrawal Syndrome
chemical_list: D009020:Morphine; D005283:Fentanyl